The first Live Webinar on Canine Leishmaniasis (CanL) of 2022 will be held by Prof. Andrea Zatelli on February 15th, beginning at 1.30 pm for about one hour including the time for questions and answers. This free access Webinar is organized with the cooperation of Ecuphar. In the webinar Prof. Zatelli will present the recent published information about the immunostimulant and nephro-protective effects of domperidone in the dog affected by leishmaniosis.
During canine leishmaniosis the immunotherapy with domperidone has been demonstrated to be promising and recent investigations evidenced its efficacy not only to decrease the antibody titer and the acute phase proteins, and the kidney function as well. Based on the current evidence domperidone is a drug with an immunostimulant and nephro-protective effects in the dog affected by leishmaniosis.
Starting from the important recent published paper on the domperidone effects in dogs affected by leishmaniosis and chronic kidney disease, in this webinar the author Prof. A. Zatelli will present the most striking evidence of this investigation. Indeed, in addition to the proved evidence of the decrease in anti-leishmania antibody titer, a recovery of serum creatinine, globulins and C-reactive protein has been statistically demonstrated.
To access to this Webinar the enrollment is necessary, and it is possible with this link:
https://attendee.gotowebinar.com/register/9079533246835527182
